NCT03283371 · Interventional trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Overall registry status Completed
Phase 2
Conditions Epilepsy, Focal Seizures, Partial Seizures
Delaware Valley sites
- Research Site · Camden, NJ · Camden County
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory